Diurnal variation in platelet inhibition by clopidogrel

Platelets

Volumn 22, Issue 8, 2011, Pages 579-587

  Kozinski, Marek ^a   Bielis, Liliana ^a   Wisniewska Szmyt, Joanna ^a   Boinska, Joanna ^a   Stolarek, Wioleta ^a   Marciniak, Agata ^a   Kubica, Aldona ^a   Grabczewska, Zofia ^a   Navarese, Eliano Pio ^a   Andreotti, Felicita ^b   Siller Matula, Jolanta Maria ^c   Rosc, Danuta ^a   Kubica, Jacek ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b CATHOLIC UNIVERSITY   (Italy)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Acute myocardial infarction; Diurnal variation; Dual antiplatelet therapy; Platelet aggregation

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; AMLODIPINE; ARACHIDONIC ACID; ATORVASTATIN; BISOPROLOL; CHOLESTEROL; CLOPIDOGREL; HEPARIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PANTOPRAZOLE; RAMIPRIL; TRIACYLGLYCEROL;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; BARE METAL STENT; BODY MASS; CHOLESTEROL BLOOD LEVEL; CIRCADIAN RHYTHM; CORONARY ARTERY BLOOD FLOW; CORONARY STENT; DIABETES MELLITUS; DIABETIC PATIENT; DRUG RESPONSE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; IMPEDANCE AGGREGOMETRY; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE FUNCTION; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL;

ADENOSINE DIPHOSPHATE; AGED; BLOOD PLATELETS; CIRCADIAN RHYTHM; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE;

EID: 80455149677     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2011.582900     Document Type: Article

References (42)

1. Meadows TA, Bhatt DL. Clinical aspects of platelet inhibitors and thrombus formation. Circ Res 2007;100:1261-1275. (Pubitemid 46742917)
2. Bryniarski L, Pelc-Nowicka A, Zabojszcz M, Mirek-Bryniarska E. Dual antiplatelet therapy and antithrombotic treatment: Recommendations and controversies. Cardiol J 2009;16:179-189.
3. Crescente M, Di Castelnuovo A, Iacoviello L, Vermylen J, Cerletti C, de Gaetano G. Response variability to aspirin as assessed by the platelet function analyzer (PFA)-100. A systematic review. Thromb Haemost 2008;99:14-26.
4. Serebruany VL, Steinhubl SR, Berger PB, Malinin AI, Bhatt DL, Topol EJ. Variability in platelet responsiveness to clopidogrel among 544 individuals. J Am Coll Cardiol 2005;45:246-251. (Pubitemid 40094733)
5. Buonamici P, Marcucci R, Migliorini A, Gensini GF, Santini A, Paniccia R, Moschi G, Gori AM, Abbate R, Antoniucci D. Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis. J Am Coll Cardiol 2007;49:2312-2317. (Pubitemid 46891710)
6. Eikelboom JW, Hankey GJ, Thom J, Bhatt DL, Steg PG, Montalescot G, Johnston SC, Steinhubl SR, Mak KH, Easton JD, et al. Clopidogrel for high atherothrombotic risk and ischemic stabilization, management and avoidance (CHARISMA) investigators. Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: Determinants and effect on cardiovascular risk. Circulation 2008;118:1705-1712.
7. Gum PA, Kottke-Marchant K, Welsh PA, White J, Topol EJ. A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol 2003;41:961-965. (Pubitemid 36315537)
8. Matetzky S, Shenkman B, Guetta V, Shechter M, Bienart R, Goldenberg I, Novikov I, Pres H, Savion N, Varon D, et al. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation 2004;109:3171-3175.
9. Chen L, Bracey AW, Radovancevic R, Cooper Jr JR, Collard CD, Vaughn WK, Nussmeier NA. Clopidogrel and bleeding in patients undergoing elective coronary artery bypass grafting. J Thorac Cardiovasc Surg 2004;128:425-431. (Pubitemid 39194700)
10. Sibbing D, Schulz S, Braun S, Morath T, Stegherr J, Mehilli J, Schömig A, von Beckerath N, Kastrati A. Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement. J Thromb Haemost 2010;8:250-256.
11. Kuliczkowski W, Witkowski A, Polonski L, Kuliczkowski W, Witkowski A, Polonski L, Watala C, Filipiak K, Budaj A, Golanski J, et al. Interindividual variability in the response to oral antiplatelet drugs: A position paper of the working group on antiplatelet drugs resistance appointed by the section of cardiovascular interventions of the polish cardiac society, endorsed by the working group on thrombosis of the European society of cardiology. Eur Heart J 2009;30:426-435.
12. Koziń ski M, Bielis L, Wiśniewska-Szmyt J, Sukiennik A, Grabczewska Z, Swiatkiewicz I, Ziõl kowski M, Rość D, Kubica J. Increased morning ADP-dependent platelet aggregation persists despite dual antiplatelet therapy in patients with first ST-segment elevation myocardial infarction: Preliminary report. Cardiol J 2008;15:530-536.
13. Beisiegel B, Treese N, Hafner G, Meyer J, Darius H. Increase in endogenous fibrinolysis and platelet activity during exercise in young volunteers. Agents Actions Suppl 1992;37:183-189.
14. Mores N, Martire M, Pistritto G, Volpe AR, Menini E, Folli G, Cardillo C. Platelet alpha 2-adrenoceptors and diurnal changes of platelet aggregability in hypertensive patients. J Hypertens 1994;12:939-945. (Pubitemid 24283378)
15. Muller JE, Stone PH, Turi ZG, Rutherford JD, Czeisler CA, Parker C, Poole WK, Passamani E, Roberts R, Robertson T. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 1985;313:1315-1322. (Pubitemid 16206020)
16. Muller JE, Tofler GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation 1989;79:733-743. (Pubitemid 19100532)
17. Tofler GH, Brezinski D, Schafer AI, Czeisler CA, Rutherford JD, Willich SN, Gleason RE, Williams GH, Muller JE. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med 1987;316:1514-1518. (Pubitemid 17076236)
18. Siller-Matula JM, Haberl K, Prillinger K, Panzer S, Lang I, Jilma B. The effect of antiplatelet drugs clopidogrel and aspirin is less immediately after stent implantation. Thromb Res 2009;123:874-880.
19. Karon BS, Wockenfus A, Scott R, Hartman SJ, McConnell JP, Santrach PJ, Jaffe AS. Aspirin responsiveness in healthy volunteers measured with multiple assay platforms. Clin Chem 2008;54:1060-1065. (Pubitemid 351793414)
20. Toth O, Calatzis A, Penz S, Losonczy H, Siess W. Multiple electrode aggregometry: A new device to measure platelet aggregation in whole blood. Thromb Haemost 2006;96:781-788. (Pubitemid 44883819)
21. Calatzis A, Wittwer M, Krueger B. A new approach to platelet function analysis in whole blood-The multiplate analyzer. Platelets 2004;15:485-486.
22. Seyfert UT, Haubelt H, Vogt A, Hellstern P. Variables influencing multiplate (TM) whole blood impedance platelet aggregometry and turbidimetric platelet aggregation in healthy individuals. Platelets 2007;18:199-206. (Pubitemid 46744118)
23. Althoff TF, Fischer M, Langer E, Ziemer S, Baumann G. Sustained enhancement of residual platelet reactivity after coronary stenting in patients with myocardial infarction compared to elective patients. Thromb Res 2010;125:e190-e196.
24. Pepine CJ. Circadian variations in myocardial ischemia. Implications for management. JAMA 1991;265:386-390.
25. Anfossi G, Trovati M. Role of catecholamines in platelet function: Pathophysiological changes of clinical significance. Eur J Clin Invest 1996;26:353-370. (Pubitemid 26171949)
26. Brezinski DA, Tofler GH, Muller JE, Pohjola-Sintonen S, Willich SN, Schafer AI, Czeisler CA, Williams GH. Morning increase in platelet aggregability. Association with assumption of the upright posture. Circulation 1988;78:35-40.
27. Kestin AS, Ellis PA, Barnard MR, Errichetti A, Rosner BA, Michelson AD. Effect of strenuous exercise on platelet activation state and reactivity. Circulation 1993;88:1502-1511. (Pubitemid 23296897)
28. Andrews NP, Gralnick HR, Merryman P, Vail M, Quyyumi AA. Mechanisms underlying the morning increase in platelet aggregation: A flow cytometry study. J Am Coll Cardiol 1996;28:1789-1795. (Pubitemid 26426236)
29. Andrews NP, Goldstein DS, Quyyumi AA. Effect of systemic alpha-2 adrenergic blockade on the morning increase in platelet aggregation in normal subjects. Am J Cardiol 1999;84:316-320. (Pubitemid 29365129)
30. Hayashi J, Sato H, Tanaka Y, Tokuue J, Ishida N, Watanabe K, Kitamoto K. Guanabenz, an antihypertensive centrally acting alpha 2-agonist, suppresses morning elevations in aggregation of human platelets. J Cardiovasc Pharmacol 2001;37:89-93. (Pubitemid 32013951)
31. Willich SN, Tofler GH, Brezinski DA, Schafer AI, Muller JE, Michel T, Colucci WS. Platelet alpha 2 adrenoceptor characteristics during the morning increase in platelet aggregability. Eur Heart J 1992;13:550-555.
32. Willich SN, Pohjola-Sintonen S, Bhatia SJ, Shook TL, Tofler GH, Muller JE, Curtis DG, Williams GH, Stone PH. Suppression of silent ischemia by metoprolol without alteration of morning increase of platelet aggregability in patients with stable coronary artery disease. Circulation 1989;79:557-565. (Pubitemid 19087706)
33. Behnke O, Forer A. From megakaryocytes to platelets: Platelet morphogenesis takes place in the bloodstream. Eur J Haematol Suppl 1998;61:3-23.
34. Haus E, Cusulos M, Sackett-Lundeen L, Swoyer J. Circadian variations in blood coagulation parameters, alpha-antitrypsin antigen and platelet aggregation and retention in clinically healthy subjects. Chronobiol Int 1990;7:203-216. (Pubitemid 20357229)
35. Husted S, Emanuelsson H, Heptinstall S, Sandset PM, Wickens M, Peters G. Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: A double-blind comparison to clopidogrel with aspirin. Eur Heart J 2006;27:1038-1047.
36. McCall NT, Tofler GH, Schafer AI, Williams GH, Muller JE. The effect of enteric-coated aspirin on the morning increase in platelet activity. Am Heart J 1991;121:1382-1388.
37. Tison P, Ulicna L, Jakubovska Z, Oravcova J, Fetkovska N. Effects of dihydropyridines and their combination with aspirin on blood pressure and circadian platelet activity in patients with essential hypertension. Am J Hypertens 1994;7:46 S-49 S. (Pubitemid 24248715)
38. Sibbing D, Braun S, Jawansky S, Vogt W, Mehilli J, Schömig A, Kastrati A, von Beckerath N. Assessment of ADP-induced platelet aggregation with optical aggregometry and multiple electrode platelet aggregometry before and after clopidogrel loading. Thromb Haemost 2008;99:121-126.
39. Dyszkiewicz-Korpanty A, Olteanu H, Frenkel EP, Sarode R. Clopidogrel anti-platelet effect: An evaluation by optical aggregometry, impedance aggregometry, and the platelet function analyzer (PFA-100). Platelets 2007;18:491-496. (Pubitemid 350034851)
40. Mengistu AM, Wolf MW, Boldt J, Röhm KD, Lang J, Piper SN. Evaluation of a new platelet function analyzer in cardiac surgery: A comparison of modified thromboelastography and whole-blood aggregometry. J Cardiothorac Vasc Anesth 2008;22:40-46. (Pubitemid 351179383)
41. Sibbing D, Braun S, Morath T, Mehilli J, Vogt W, Schömig A, Kastrati A, von Beckerath N. Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis. J Am Coll Cardiol 2009;53:849-856.
42. Siller-Matula JM, Christ G, Lang IM, Delle-Karth G, Huber K, Jilma B. Multiple electrode aggregometry better predicts stent thrombosis than the VASP assay. J Thromb Haemost 2010;8:351-359.